Business directory profile
Mediwin Research & Healthcare – Leading Pharmaceutical Company in India
In Ambala, Mediwin Research & Healthcare – Leading Pharmaceutical Company in India is known as a pharma r&d / laboratory focused on r&d / lab services.
In this guide
About Mediwin Research & Healthcare – Leading Pharmaceutical Company in India
In Ambala, Mediwin Research & Healthcare – Leading Pharmaceutical Company in India is known as a pharma r&d / laboratory focused on r&d / lab services. The organisation’s bio centres on practical pharmaceutical services, facility presence, and the commercial roles that keep medicines and related healthcare products moving through the market.
Published milestones and timeline notes include: an established presence in Ambala. Contributes to the regional pharmaceutical ecosystem of Ambala.
Maintains an official web presence for product and corporate information. Interesting public facts attached to the company include: Mediwin Research & Healthcare – Leading Pharmaceutical Company in India is associated with pharmaceutical manufacturing/lab operations, typically involving quality, production, and compliance-driven roles.
Official website available for verification of products, locations, and…. Operationally, Mediwin Research & Healthcare – Leading Pharmaceutical Company in India is associated with premises at 11 to 20, Vita Enclave, Dhulkot Road, Near Sena Nagar, Ambala, Haryana – 134003, India.
For a pharma r&d / laboratory, site context influences warehousing, quality documentation, staffing patterns, and how quickly commercial or technical teams can respond to partner requests. As a pharma r&d / laboratory, Mediwin Research & Healthcare – Leading Pharmaceutical Company in India’s service profile typically covers the workstreams implied by that classification — for example manufacturing support, formulation supply, API-related handling, wholesale or dealer distribution, franchise marketing, packaging services, laboratory work, or corporate coordination.
More specifically, available descriptors emphasise r&d / lab services, which helps explain what partners can expect when engaging the company for supply, outsourcing, or commercial collaboration. The business is frequently associated with: Pharmaceutical Manufacturers in Ambala.
Search and discovery cues linked to this profile include themes such as “pharma companies in ambala”, reflecting how buyers and candidates encounter the brand online. Ownership is described as Private.
Workforce size is publicly estimated in the 51–200 range, noting that headcount can differ across plants, depots, and corporate offices. Students, freshers, and experienced professionals exploring careers with Mediwin Research & Healthcare – Leading Pharmaceutical Company in India should confirm live vacancies on official career channels, because openings vary by function — QA/QC, production, regulatory, sales, supply chain, and R&D support.
For business enquiries, partnerships, or site visits, listed contacts include phone +91 92150 45514. Taken together, the available information sketches Mediwin Research & Healthcare – Leading Pharmaceutical Company in India as an active pharma r&d / laboratory with a defined footprint in Ambala, a clear service emphasis, and contact channels for commercial or career follow-up.
Mediwin Research & Healthcare – Leading Pharmaceutical Company in India is associated with pharmaceutical manufacturing/lab operations, typically involving quality, production, and compliance-driven roles. Official website available for verification of products, locations, and careers. Common job-profile fit signals for this listing: Production Chemist.
Services and focus
Mediwin Research & Healthcare – Leading Pharmaceutical Company in India is listed under Pharmaceutical Manufacturers in Ambala. Its published profile states a focus on r&d / lab services. Ownership is described as Private.
- Manufacturing support
- Formulation supply
- API-related handling
- Wholesale or dealer distribution
- Franchise marketing
- Packaging services
- Laboratory work
- Corporate coordination
Job profiles commonly associated with this listing include Production Chemist.
Key facts
| Business name | Mediwin Research & Healthcare – Leading Pharmaceutical Company in India |
|---|---|
| Category | Pharmaceutical Manufacturers |
| Location | Ambala, Haryana |
| Listed address | 11 to 20, Vita Enclave, Dhulkot Road, Near Sena Nagar, Ambala, Haryana – 134003, India |
| Ownership | Private |
| Workforce (public estimate) | 51–200 employees |
| Listed focus | r&d / lab services |
Pharmaceutical Manufacturers in Ambala
VisitBest lists 145 Pharmaceutical Manufacturers profiles in its business directory, including 17 in Ambala, Haryana. Across all categories, 86 businesses are listed in Ambala.
Other Pharmaceutical Manufacturers listed in Ambala include Maxnova Healthcare Corporate Office, Riyadh Pharmaceutical, Wannock Pharmaceuticals !! Best PCD PHARMA FRANCHISE / MONOPOLY PHARMA COMPANY in Ambala Haryana ,Chandigarh , Panchkula, Ben Pharmaceuticals.
Frequently asked questions
Where is Mediwin Research & Healthcare – Leading Pharmaceutical Company in India located?
Its listed address is 11 to 20, Vita Enclave, Dhulkot Road, Near Sena Nagar, Ambala, Haryana – 134003, India.
What does Mediwin Research & Healthcare – Leading Pharmaceutical Company in India do?
Mediwin Research & Healthcare – Leading Pharmaceutical Company in India is listed as Pharmaceutical Manufacturers in Ambala. Its published descriptors emphasise r&d / lab services. Its service profile typically covers manufacturing support, formulation supply, API-related handling, wholesale or dealer distribution.
How large is Mediwin Research & Healthcare – Leading Pharmaceutical Company in India?
Public workforce listings estimate Mediwin Research & Healthcare – Leading Pharmaceutical Company in India's workforce in the 51–200 range. Ownership is described as Private.
How can I verify this listing?
Directory information is compiled from public sources. Verify the current address, services, and contact details with the organisation directly before a commercial decision.